SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-008128
Filing Date
2019-02-14
Accepted
2019-02-14 16:22:48
Documents
68
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv512542_10q.htm 10-Q 411446
2 EXHIBIT 31.1 tv512542_ex31-1.htm EX-31.1 7522
3 EXHIBIT 32.1 tv512542_ex32-1.htm EX-32.1 3976
  Complete submission text file 0001144204-19-008128.txt   3835203

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ons-20181231.xml EX-101.INS 583633
5 XBRL TAXONOMY EXTENSION SCHEMA ons-20181231.xsd EX-101.SCH 53233
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ons-20181231_cal.xml EX-101.CAL 36284
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ons-20181231_def.xml EX-101.DEF 249200
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ons-20181231_lab.xml EX-101.LAB 476558
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ons-20181231_pre.xml EX-101.PRE 364772
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37759 | Film No.: 19606773
SIC: 2836 Biological Products, (No Diagnostic Substances)